Science | ABNewswire

Hypercholesterolemia Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight

DelveInsight’s, “Hypercholesterolemia Pipeline Insight, 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Hypercholesterolemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product … Continue reading →

Peanut Allergy Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Peanut Allergy Pipeline Insight, 2026” report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in Peanut Allergy pipeline landscape. It covers the Peanut Allergy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Mesothelioma Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Mesothelioma Pipeline Insight 2026” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in the mesothelioma pipeline landscape. It covers the Mesothelioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Mesothelioma therapeutics … Continue reading →

Interstitial Lung Disease Clinical Trial Pipeline Expands as 120+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Interstitial Lung Diseases Pipeline Insight 2026” report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in the Interstitial Lung Disease pipeline landscape. It covers the Interstitial Lung Diseases pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Rett Syndrome Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Rett Syndrome Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Rett Syndrome pipeline landscape. It covers the Rett Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

DIVEVOLK Makes History as Exclusive Sponsor of First-Ever Smartphone Category at Underwater Photographer of the Year (UPY) 2026

Chinese Photographer Jack Ho Wins Inaugural Award with Hairy Frogfish Macro Shot Captured on a Smartphone in DIVEVOLK SeaTouch 4 Max Platinum V2 Housing London, UK – March 24, 2026 – DIVEVOLK, a global leader in smartphone underwater housing technology, today announced … Continue reading →

1752vc Welcomes Grace Cupat as Senior AI Engineer to Advance Platform and AI Infrastructure

1752vc has recently hired Grace Cupat as Senior AI Engineer, strengthening its AI infrastructure and advancing its vision of becoming an AI-first venture platform. Santa Monica, CA – March 24, 2026 – 1752vc recently hired Grace Cupat as Senior AI Engineer, … Continue reading →

QuickLaunch Analytics Named Fivetran’s Resell Rising Star Partner of the Year

Award recognizes QuickLaunch’s rapid growth and early impact as a Fivetran resell partner, with both companies looking to expand their collaboration in 2026 San Francisco, CA – March 24, 2026 – QuickLaunch Analytics, a leading enterprise analytics platform provider, has been … Continue reading →

Diarrhea Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Diarrhea Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in the Diarrhea pipeline landscape. It covers the Diarrhea Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diarrhea Pipeline … Continue reading →

Diabetes Clinical Trial Pipeline Shows Potential with Active Contributions from 200+ Key Companies | DelveInsight

DelveInsight’s “Diabetes Pipeline Insight 2026” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in the Diabetes pipeline landscape. It covers the Diabetes pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetes therapeutics … Continue reading →

Monday - March 30, 2026

Category Archives: Science